Piperazinylpyrimidines as beta-adrenergic receptor blocking agents
申请人:Merck & Co., Inc.
公开号:EP0276057A2
公开(公告)日:1988-07-27
Certain piperazinylpyrimidines have pronounced β-adrenergic blocking properties and some of the compounds are particularly useful in the treatment of elevated intraocular pressure and glaucoma.